HSP90AB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.964500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.598800E-01
Normal-vs-Stage2
4.503200E-01
Normal-vs-Stage3
9.330200E-01
Normal-vs-Stage4
3.676200E-02
Stage1-vs-Stage2
8.913200E-01
Stage1-vs-Stage3
3.790800E-01
Stage1-vs-Stage4
4.543500E-02
Stage2-vs-Stage3
3.349400E-01
Stage2-vs-Stage4
7.302100E-02
Stage3-vs-Stage4
6.767800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.844400E-03
Normal-vs-AfricanAmerican
4.463200E-01
Normal-vs-Asian
5.949200E-01
Caucasian-vs-AfricanAmerican
5.960400E-01
Caucasian-vs-Asian
3.842400E-01
AfricanAmerican-vs-Asian
8.833800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.043200E-04
Normal-vs-Female
4.841400E-01
Male-vs-Female
8.720400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.931200E-01
Normal-vs-Age(41-60Yrs)
2.588100E-04
Normal-vs-Age(61-80Yrs)
4.902400E-01
Normal-vs-Age(81-100Yrs)
1.062250E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.269400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.256000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.560630E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.735500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.192400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.203800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.606800E-01
Normal-vs-Daily Drinker
6.316800E-01
Normal-vs-Weekly Drinker
5.146000E-01
Normal-vs-Occasional Drinker
1.642360E-03
Normal-vs-Social Drinker
4.606600E-01
Non Drinker-vs-Daily Drinker
8.765800E-01
Non Drinker-vs-Weekly Drinker
9.400200E-01
Non Drinker-vs-Occasional Drinker
1.203770E-02
Non Drinker-vs-Social Drinker
8.202600E-01
Daily Drinker-vs-Weekly Drinker
9.476600E-01
Daily Drinker-vs-Occasional Drinker
1.135770E-02
Daily Drinker-vs-Social Drinker
9.431200E-01
Weekly Drinker-vs-Occasional Drinker
1.234430E-02
Weekly Drinker-vs-Social Drinker
8.775000E-01
Occasional Drinker-vs-Social Drinker
7.960900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.133400E-01
Normal-vs-Grade 2
1.391160E-01
Normal-vs-Grade 3
1.094800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.389400E-01
Grade 1-vs-Grade 3
4.627800E-01
Grade 1-vs-Grade 4
3.133400E-01
Grade 2-vs-Grade 3
6.377000E-01
Grade 2-vs-Grade 4
1.391160E-01
Grade 3-vs-Grade 4
1.094800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.438300E-02
Normal-vs-NonDiabetic
3.725000E-01
Diabetic-vs-NonDiabetic
5.725400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.215160E-01
Normal-vs-NoPancreatitis
4.596600E-03
Pancreatitis-vs-NoPancreatitis
5.879800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.905180E-01
Normal-vs-N1
1.019630E-02
N0-vs-N1
4.357600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.47329999999435E-05
Normal-vs-TP53-NonMutant
1.692260E-02
TP53-Mutant-vs-TP53-NonMutant
6.178200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
